• 1. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 2. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 3. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383

5-Amino-6-bromonicotinaldehyde (CAS 1289176-76-6): A Versatile Building Block in Organic Synthesis

5-Amino-6-bromonicotinaldehyde (CAS 1289176-76-6) is a highly valuable heterocyclic compound that has gained significant attention in pharmaceutical research and organic synthesis. This nicotinaldehyde derivative serves as a crucial intermediate for the preparation of various biologically active molecules, particularly in the development of kinase inhibitors and anticancer agents.

The molecular structure of 5-amino-6-bromonicotinaldehyde features three strategically positioned functional groups: an aldehyde moiety, an amino group, and a bromine substituent. This unique combination makes it an exceptionally versatile building block for medicinal chemistry applications. Recent studies highlight its importance in the synthesis of targeted therapies, especially in the context of precision medicine approaches that are currently revolutionizing healthcare.

From a chemical properties perspective, 5-amino-6-bromonicotinaldehyde demonstrates excellent reactivity in various cross-coupling reactions, including Suzuki-Miyaura and Buchwald-Hartwig couplings. Its bromine atom serves as an excellent leaving group, while the aldehyde functionality allows for further derivatization through condensation reactions or reductive amination. These characteristics make it particularly valuable for constructing complex nitrogen-containing heterocycles, which are prevalent in many FDA-approved drugs.

The pharmaceutical applications of 5-amino-6-bromonicotinaldehyde are particularly noteworthy in the development of tyrosine kinase inhibitors. With the growing demand for cancer therapeutics and the increasing focus on personalized medicine, this compound has become increasingly important in drug discovery pipelines. Researchers are particularly interested in its potential for creating selective inhibitors that can target specific oncogenic pathways while minimizing side effects.

In the context of green chemistry and sustainable synthesis, 5-amino-6-bromonicotinaldehyde offers several advantages. Its well-defined reactivity patterns often allow for atom-economical transformations, reducing waste in multi-step syntheses. Furthermore, the compound's stability under various conditions makes it suitable for flow chemistry applications, which are gaining popularity in industrial-scale pharmaceutical production.

The market demand for 5-amino-6-bromonicotinaldehyde has been steadily increasing, driven by the expansion of contract research organizations and the growing drug discovery sector. Analytical data shows a compound annual growth rate (CAGR) of approximately 8-10% for similar pharmaceutical intermediates over the past five years. This trend is expected to continue as more biotech startups focus on developing targeted small molecule therapies.

Quality control of 5-amino-6-bromonicotinaldehyde typically involves advanced analytical techniques such as HPLC purity analysis, mass spectrometry, and NMR spectroscopy. These methods ensure the compound meets the stringent requirements for pharmaceutical-grade materials. The standard purity for research applications typically exceeds 97%, with higher grades (≥99%) available for critical drug development applications.

From a storage and handling perspective, 5-amino-6-bromonicotinaldehyde should be kept in a cool, dry environment, protected from light and moisture. While not classified as highly sensitive, proper chemical storage protocols help maintain its stability over extended periods. The compound's shelf life can be significantly extended when stored under inert atmosphere at temperatures between 2-8°C.

Recent scientific literature highlights several innovative applications of 5-amino-6-bromonicotinaldehyde in materials science beyond its traditional pharmaceutical uses. Researchers are exploring its potential in the synthesis of organic electronic materials and coordination complexes with unique photophysical properties. These developments align with current interests in functional materials for optoelectronic applications.

The regulatory landscape surrounding 5-amino-6-bromonicotinaldehyde is relatively straightforward, as it is primarily used as a research chemical rather than a final drug product. However, researchers should always consult local regulations regarding the safe handling of chemicals and proper laboratory safety protocols. The compound's safety data sheet (SDS) provides comprehensive information about appropriate personal protective equipment and emergency procedures.

Looking toward the future, 5-amino-6-bromonicotinaldehyde is poised to play an increasingly important role in drug discovery as the pharmaceutical industry continues to focus on targeted cancer therapies and precision medicine. Its versatility as a chemical building block, combined with the growing understanding of its structure-activity relationships, ensures it will remain a valuable tool for medicinal chemists developing the next generation of therapeutic agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)